![Surrogate endpoints in HTA: Reflections on my HTAi panel discussion cover](https://mtechaccess.co.uk/wp-content/uploads/2024/06/surrogate-endpoints-in-hta_826ac21f9c5c7fdaac5b03521c69d22a_2000-1024x536.jpg)
Calum Jones (Associate Director – Health Economics) shares his experience speaking at the 2024 HTAi Conference. Calum participated in the panel discussion: ‘Surrogate Endpoints in Health Technology Assessment (HTA): From Trials to Economic Evaluations’.